Outpatient Thyroid Remnant Ablation Using Repeated Low 131-Iodine Activities (740 MBq/20 mCi × 2) in Patients with Low-Risk Differentiated Thyroid Cancer-Reference-Cited by-同舟云学术

Outpatient Thyroid Remnant Ablation Using Repeated Low 131-Iodine Activities (740 MBq/20 mCi × 2) in Patients with Low-Risk Differentiated Thyroid Cancer

Published:2012-03-01 Issue:3 Volume:97 Page:871-880
ISSN:0021-972X
Container-title:The Journal of Clinical Endocrinology & Metabolism
language:en
Short-container-title:

Author:

Clerc Jérôme¹,Bienvenu-Perrard Marie¹,de Malleray Caroline Pichard¹²,Dagousset Françoise²,Delbot Thierry¹,Dreyfuss Marc¹,Groussin Lionel²,Marlowe Robert J.³,Leger Françoise Aubène¹,Chevalier Alain¹

Affiliation:

1. Departments of Nuclear Medicine (J.C., M.B.-P., C.P.M., F.D., T.D., M.D., F.A.L., A.C.), 75679 Paris, France

2. Endocrinology (C.P.M., F.D., L.G.), Université René Descartes Sorbonne Paris Cité, Assistance Publique Hôpitaux de Paris, 75679 Paris, France

3. Spencer-Fontayne Corporation (R.J.M.), Jersey City, New Jersey 07304-1901

Publisher

The Endocrine Society

Subject

Biochemistry (medical),Clinical Biochemistry,Endocrinology,Biochemistry,Endocrinology, Diabetes and Metabolism

Link

http://academic.oup.com/jcem/article-pdf/97/3/871/10416026/jcem0871.pdf

Reference30 articles.

1. What is the optimal initial treatment of low-risk papillary thyroid cancer (and why is it controversial)?;Mazzaferri;Oncology,2009

2. Extent of surgery affects survival for papillary thyroid cancer.;Bilimoria;Ann Surg,2007

3. Follow-up of low-risk differentiated thyroid cancer patients who underwent radioiodine ablation of postsurgical thyroid remnants after either recombinant human thyrotropin or thyroid hormone withdrawal.;Elisei;J Clin Endocrinol Metab,2009

4. Revised American Thyroid Association management guidelines for patients with thyroid nodules and differentiated thyroid cancer.;Cooper;Thyroid,2009

5. Ablation of thyroid residues with 30 mCi (131)I: a comparison in thyroid cancer patients prepared with recombinant human TSH or thyroid hormone withdrawal.;Pacini;J Clin Endocrinol Metab,2002

Cited by 12 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Comparison of 1.1 GBq and 2.2 GBq Activities in Patients with Low-Risk Differentiated Thyroid Cancer Requiring Postoperative 131I Administration: A Real Life Study;Cancers;2023-04-22

2. Imagerie moléculaire et biomarqueurs des cancers thyroïdiens de souche vésiculaire : recommandations 2017 de SFMN/SFE/SFP/SFBC/AFCE/SFORL;Médecine Nucléaire;2017-11

3. Traitement par iode 131 des cancers thyroïdiens différenciés : recommandations 2017 des sociétés françaises SFMN/SFE/SFP/SFBC/AFCE/SFORL;Médecine Nucléaire;2017-11

4. Radioiodine treatment after surgery for differentiated thyroid cancer: a reasonable option;European Journal of Nuclear Medicine and Molecular Imaging;2017-02-17

5. The Result of Multiple I-131 Treatments on the Effective Half-Life of Retained Radioactivity in Patients Ablated for Differentiated Thyroid Cancer: Possible Evidence for Thyroid Remnant Function Impairment;Cancer Biotherapy and Radiopharmaceuticals;2016-03